Enzyme alterable alkylating agents. 8. Clinical trials with intra-arterial infusion of an alkylating agent with a half-life of 0.2 second by Goodman, L E, Ulfohn, A, Kramer, S P, Cendana, E H, Flores, A B, Bakal, D, Abrams, S J, Hirschfeld, R L, Calle, S, Williamson, C E, Sass, S, Witten, B, Seligman, A M

Get full text

Decision support system to determine hydroponic vegetable cultivation based on Internet of Things (IoT) by Putra, E I, Cendana, M, Yaddarabullah, Y

Get full text

CLINICAL EXPERIENCE WITH N-HEXAMETHYLENE N'N'-DIETHYLENE THIOPHOSPHORAMIDE (KC-33), A NEW AGENT FOR BREAST AND OVARIAN CARCINOMA by GOODMAN, L E, BAKAL, D, TSOU, K C, KRAMER, S P, ULFOHN, A, GABY, S D, DORFMAN, H E, AYBAR, O, CENDANA, E, ASCOLI, M G, SELIGMAN, A M

Get full text

An HPLC‐UV method for determining plasma dimethylacetamide concentrations in patients receiving intravenous busulfan by Cendana, Mildred, Lee, Samiuela, Upadhyay, Parth J., Byrne, Jennifer A., Shaw, Peter J., Earl, John, Nath, Christa E.

Get full text

A Team Approach to Improving Tissue Management by Sions, Jacqueline A., MSN, RN, CNOR, NE-BC, Cheuvront, Kimberly A., PhD, MT, Grove, Georgiana L., BSN, RN, CNOR, Beach, Myra J., MBA, BSN, RN, CNOR, NE-BC, Bowers, Jay W., BSN, RN, CNOR, Cendaña, Cinthia R., BSN, RN, CNOR, Hixson, Jesse R., MSN, RN, CNOR, Wilson, Mary C., BSN, RN, CNOR

Get full text

Primary and secondary agonists can use P2X1 receptors as a major pathway to increase intracellular Ca2+ in the human platelet by FUNG, C. Y. E., CENDANA, C., FARNDALE, R. W., MAHAUT‐SMITH, M. P.

Get full text

Primary and secondary agonists can use P2X(1) receptors as a major pathway to increase intracellular Ca(2+) in the human platelet by Fung, C Y E, Cendana, C, Farndale, R W, Mahaut-Smith, M P

Get full text

Enzyme Alterable Alkylating Agents by Goodman, Louis E., Ulfoiin, Adolpii, Kramer, Stanley P., Cendana, Elena H., Flores, Audberto B., Bakal, Daxiel, Abrams, Samuel J., Hurschfeld, Robert L., Calle, Simon, Williamson, Charles E., Sass, Samuel, Witten, Benjamin, Seligman, Arnold M.

Get full text

Clinical experience with N‐hexamethylene N′N″‐diethylene thiophosphoramide (KC‐33), a new agent for breast and ovarian carcinoma by Goodman, Louis E., Bakal, Daniel, Tsou, Kwan‐Chung, Kramer, Stanley P., Ulfohn, Adolph, Gaby, Samuel D., Dorfman, Howard E., Aybar, Olimpia, Cendana, Elena, Ascoli, Maria G., Seligman, Arnold M.

Get full text